Sanofi Alliance Is Big Boost For Company Behind Type 1 Diabetes Prevention Drug

Provention’s Therapy Delays Onset By Three Years

 
• By Andrew McConaghie
  
Sanofi logo
Sanofi has exited Type 1 diabetes research, but retains a large commercial infrastructure in the US and worldwide. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip